MSF's publications are an expression of our belief in the principle of témoignage, or bearing witness, and the belief that we are accountable to those we work for and with. Sharing news about our activities and reflecting on them, offering critiques when necessary, are therefore crucial aspects of our work.

View and download these publications below.

To view the U.S. Annual Reports or International Activity Reports, please visit the Annual Reports page.

Country/Region

10.30.2014

A survey of TB diagnostic and treatment practices in eight countries, October 2014.

MSF briefing paper, December 2014

What began in 2011 in Syria as protests inspired by the Arab Spring has become an entrenched and bloody conflict that shows no sign of resolution. Today, with an estimated 200,000 people killed and 7.6 million people displaced within the country and 3.2 million refugees registered outside, Syria is seen as the world’s most grave humanitarian disaster. In the face of this crisis, the previously functioning health system has collapsed and scores of thousands of medical staff have fled.

Iraq experienced a dramatic surge in violence in 2014 that triggered successive large-scale waves of displacement. More than 2.6 million people are said to have fled war-torn the central and northern areas of Iraq, particularly Al-Anbar, Ninawa, Salah Al-Din, Kirkuk and Diyala governorates.

March 26, 2015

Take a glimpse at Doctors Without Borders/Médecins Sans Frontières (MSF) activities in the past month.

March 23, 2015

The world has never seen such a deadly and widespread outbreak of Ebola as the one that struck West Africa in March 2014 and continues one year later. This video gives an abbreviated look at the impact of the outbreak on people in Guinea, Sierra Leone and Liberia, and the work of Doctors Without Borders/Médecins Sans Frontières (MSF), which was at the forefront of the medical response and advocated continually for a strong international response.

March 23, 2015

The Ebola epidemic in West Africa deeply impacted public opinion at an international level. Doctors Without Borders/Médecins Sans Frontières (MSF) received massive financial support from thousands of donors all over the world. In 2014 alone, 70 million euros (approximately $93 million) were received through private donations, and 15 million (approximately $20 million) through public funds.

March 20, 2015

A selection of MSF-authored medical articles on the ongoing Ebola outbreak in West Africa.

March 20, 2015

MSF releases a critical analysis of the global Ebola response one year into the deadliest outbreak in history.

March 20, 2015

On March 20, a patient tested positive for Ebola in Monrovia, which was the first confirmed case in Liberia in more than two weeks.  A total of 150 new confirmed cases were reported across Guinea and Sierra Leone in the week ending March 15. The virus has now infected more than 24,700 people across the region since the outbreak was declared a year ago.

March 02, 2015

The Ebola outbreak in West Africa continues, albeit with decreasing intensity. The virus has infected more than 23,700 people across the region since the outbreak was declared 11 months ago. While the number of new patients in Liberia is declining, numbers are still fluctuating in both Guinea and Sierra Leone. A total of 99 new confirmed cases was reported across the three worst-affected countries during the week up to February 22, 2015.

February 26, 2015

Creating awareness is a key component of the response to an Ebola epidemic. It is impossible to eradicate the disease without the population’s support and changes in behavior.

February 24, 2015

Initial results of a clinical trial of the experimental drug favipiravir suggest that it can reduce mortality among patients with low levels of the Ebola virus in their blood, but is ineffective for patients with high viral loads who are very sick with the disease.

February 24, 2015

Initial results of a clinical trial of the experimental drug favipiravir suggest that it can reduce mortality among patients with low levels of the Ebola virus in their blood, but is ineffective for patients with high viral loads who are very sick with the disease.

Pages